HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Typical achondroplasia secondary to a unique insertional variant of FGFR3 with in vitro demonstration of its effect on FGFR3 function.

Abstract
We describe an individual in whom clinical and radiographic features are typical for achondroplasia, but in whom the common variants of FGFR3 that result in achondroplasia are absent. Whole exome sequencing demonstrated a novel, de novo 6 base pair tandem duplication in FGFR3 that results in the insertion of Ser-Phe after position Leu324. in vitro studies showed that this variant results in aberrant dimerization, excessive spontaneous phosphorylation of FGFR3 dimers and excessive, ligand-independent tyrosine kinase activity. Together, these data suggest that this variant leads to constitutive disulfide bond-mediated dimerization, and that this, surprisingly, occurs to an extent similar to the neonatal lethal thanatophoric dysplasia type I Ser249Cys variant.
AuthorsApril N Meyer, Peggy Modaff, Clark G Wang, Elizabeth Wohler, Nara L Sobreira, Daniel J Donoghue, Richard M Pauli
JournalAmerican journal of medical genetics. Part A (Am J Med Genet A) Vol. 185 Issue 3 Pg. 798-805 (03 2021) ISSN: 1552-4833 [Electronic] United States
PMID33368972 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2020 Wiley Periodicals LLC.
Chemical References
  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3
Topics
  • Achondroplasia (genetics, metabolism, pathology)
  • Adolescent
  • Adult
  • Female
  • Humans
  • Male
  • Mutation
  • Phosphorylation
  • Prognosis
  • Receptor, Fibroblast Growth Factor, Type 3 (genetics, metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: